Jazz Pharmaceuticals Plc Earnings

Jazz Pharmaceuticals Plc’s revenue jumped 7.53% since last year same period to $1088.17Mn in the Q4 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 3.15% jump in its revenue since last 3-months.

Jazz Pharmaceuticals Plc’s net profit jumped 102.98% since last year same period to $191.12Mn in the Q4 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -11.13% fall in its net profits since last 3-months.

Jazz Pharmaceuticals Plc’s net profit margin jumped 88.76% since last year same period to 17.56% in the Q4 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated -13.84% fall in its net profit margins since last 3-months.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 5.81 - a 5.65% jump from last quarter’s estimates.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 5.81.

Jazz Pharmaceuticals Plc’s earning per share (EPS) jumped 31.47% since last year same period to 6.6 in the Q4 2024. This indicates that the Jazz Pharmaceuticals Plc has generated 31.47% annual rate of jump in its earning per share (EPS) in the last 4 quarters.